RSV antibody shot nirsevimab gets FDA approval to protect infants from virus
Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.
Source: abc7.com
Stay updated with breaking news from Fda Rsv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.
Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.